1. Survival and Clinical Outcomes of Tunneled Central Jugular and Femoral Catheters in Prevalent Hemodialysis Patients
- Author
-
José Carlos Peña-Rodríguez, Jesus Manolo Ramos-Gordillo, and Gerardo Guillermo-Corpus
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,030232 urology & nephrology ,Vascular access ,030204 cardiovascular system & hematology ,Disease-Free Survival ,03 medical and health sciences ,Sex Factors ,0302 clinical medicine ,Renal Dialysis ,Risk Factors ,Diabetes mellitus ,medicine ,Central Venous Catheters ,Humans ,Prospective Studies ,Tunneled catheter ,Aged ,business.industry ,Hematology ,General Medicine ,Blood flow ,Femoral Vein ,Middle Aged ,medicine.disease ,Infection rate ,Surgery ,Survival Rate ,Catheter ,Nephrology ,Catheter-Related Infections ,cardiovascular system ,Female ,Hemodialysis ,Jugular Veins ,business ,Follow-Up Studies - Abstract
Background: The literature on the outcomes of tunneled femoral catheters compared to that of jugular catheters is scarce and derived mainly from small cohorts. Material and Methods: Seven hundred and sixty six catheters were placed in 673 hemodialysis patients, 622 in the jugular/subclavian veins and 144 in the femoral veins. Patients were followed prospectively for 36 months. Results: The survival of the tunneled catheters was 771 days 95% CI (737–805) for jugular and 660 days 95% CI (582–739) for femoral veins. Blood flow (0.292 ± 0.003 L/min) and infection rate (0.25 × 1,000 days/catheter) were similar for upper and lower extremities vascular accesses. Factors including sex, age, diabetes and previous catheters did not affect the outcome. Conclusions: Femoral catheters provide outstanding vascular access with excellent, function and low risk of infection.
- Published
- 2018
- Full Text
- View/download PDF